問卷

TPIDB > Search Result

Search Result

篩選

List

83Cases

2023-11-01 - 2028-12-31

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Recruiting8Sites

2021-03-17 - 2025-06-15

Phase III

A Phase 3 Open-Label, Randomized Study of LOXO-305 versus Investigator Choice of BTK Inhibitor in Patients with Previously Treated BTK Inhibitor Naïve Mantle Cell Lymphoma (BRUIN MCL-321)
  • Condition/Disease

    Lymphoma, Mantle-Cell

  • Test Drug

    LOXO-305

Participate Sites
4Sites

Recruiting4Sites